Balyasny Asset Management
CAI

Balyasny Asset Management’s Caris Life Sciences, Inc. Common Stock CAI Stock Holding History

Balyasny Asset Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1.35M Buy
+50,370
New +$1.35M ﹤0.01% 1296